US FDA Teases Disclosure Program, But Industry Has Seen This Before

 
• By Derrick Gingery
  
Will consolidation of the FDA's FOIA/disclosure staff limit the resources available to redact documents for public release? (Shutterstock)

More from Complete Response Letters

More from Product Reviews